Combined Expression of JHDM1D/KDM7A Gene and Long Non-coding RNA RP11-363E7.4 As a Biomarker for Urothelial Cancer Prognosis

Overview

Journal Genet Mol Biol

Specialty Genetics

Date 2024 Aug 13

PMID 39136575

Authors

Glenda Nicioli da Silva

Isadora Oliveira Ansaloni Pereira

Ana Paula Braga Lima

Tamires Cunha Almeida

Andre Luiz Ventura Savio

Renato Prado Costa

Katia Ramos Moreira Leite

Daisy Maria Favero Salvadori

Affiliations

Soon will be listed here.

Abstract

Bladder cancer is the tenth most frequently diagnosed cancer globally. Classification of high- or low-grade tumors is based on cytological differentiation and is an important prognostic factor. LncRNAs regulate gene expression and play critical roles in the occurrence and development of cancer, however, there are few reports on their diagnostic value and co-expression levels with genes, which may be useful as specific biomarkers for prognosis and therapy in bladder cancer. Thus, we performed a marker lesion study to investigate whether gene/lncRNA expression in urothelial carcinoma tissues may be useful in differentiating low-grade and high-grade tumors. RT-qPCR was used to evaluate the expression of the JHDM1D gene and the lncRNAs CTD-2132N18.2, SBF2-AS1, RP11-977B10.2, CTD-2510F5.4, and RP11-363E7.4 in 20 histologically diagnosed high-grade and 10 low-grade tumors. A protein-to-protein interaction network between genes associated with JHDM1D gene was constructed using STRING website. The results showed a moderate (positive) correlation between CTD-2510F5.4 and CTD2132N18.2. ROC curve analyses showed that combined JHDM1D and RP11-363E7.4 predicted tumor grade with an AUC of 0.826, showing excellent accuracy. In conclusion, the results indicated that the combined expression of JHDM1D and RP11-363E7.4 may be a prognostic biomarker and a promising target for urothelial tumor therapy.

References

Wang P, Li J, Zhao W, Shang C, Jiang X, Wang Y . A Novel LncRNA-miRNA-mRNA Triple Network Identifies LncRNA RP11-363E7.4 as An Important Regulator of miRNA and Gene Expression in Gastric Cancer. Cell Physiol Biochem. 2018; 47(3):1025-1041. DOI: 10.1159/000490168. View

Marttila S, Chatsirisupachai K, Palmer D, de Magalhaes J . Ageing-associated changes in the expression of lncRNAs in human tissues reflect a transcriptional modulation in ageing pathways. Mech Ageing Dev. 2019; 185:111177. PMC: 6961210. DOI: 10.1016/j.mad.2019.111177. View

Chen C, Wang X, Liu T, Tang X, Liu Y, Liu T . Overexpression of long non-coding RNA RP11-363E7.4 inhibits proliferation and invasion in gastric cancer. Cell Biochem Funct. 2020; 38(7):921-931. PMC: 7586934. DOI: 10.1002/cbf.3514. View

Jones R, Felsenstein K, Theodorescu D . Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer. Urol Clin North Am. 2015; 43(1):77-86. PMC: 4663013. DOI: 10.1016/j.ucl.2015.08.007. View

Pereira I, Silva G, Almeida T, Lima A, Savio A, Leite K . LncRNA Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells. Molecules. 2023; 28(5). PMC: 10005151. DOI: 10.3390/molecules28052412. View

Chen R, Xia W, Wang S, Xu Y, Ma Z, Xu W . Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma. Mol Ther Nucleic Acids. 2019; 16:543-553. PMC: 6506611. DOI: 10.1016/j.omtn.2019.04.004. View

Scholtes M, Alberts A, Ifle I, Verhagen P, van der Veldt A, Zuiverloon T . Biomarker-Oriented Therapy in Bladder and Renal Cancer. Int J Mol Sci. 2021; 22(6). PMC: 7999814. DOI: 10.3390/ijms22062832. View

Zha W, Li X, Tie X, Xing Y, Li H, Gao F . The molecular mechanisms of the long noncoding RNA SBF2-AS1 in regulating the proliferation of oesophageal squamous cell carcinoma. Sci Rep. 2021; 11(1):805. PMC: 7804443. DOI: 10.1038/s41598-020-80817-w. View

Lenis A, Lec P, Chamie K, Mshs M . Bladder Cancer: A Review. JAMA. 2020; 324(19):1980-1991. DOI: 10.1001/jama.2020.17598. View

10.

Mattick J, Amaral P, Carninci P, Carpenter S, Chang H, Chen L . Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023; 24(6):430-447. PMC: 10213152. DOI: 10.1038/s41580-022-00566-8. View

11.

Mandrekar J . Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010; 5(9):1315-6. DOI: 10.1097/JTO.0b013e3181ec173d. View

12.

Mooz J, Oberoi-Khanuja T, Harms G, Wang W, Jaiswal B, Seshagiri S . Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration. Sci Signal. 2014; 7(337):ra73. DOI: 10.1126/scisignal.2005484. View

13.

Andersen C, Jensen J, Orntoft T . Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004; 64(15):5245-50. DOI: 10.1158/0008-5472.CAN-04-0496. View

14.

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

15.

Akoglu H . User's guide to correlation coefficients. Turk J Emerg Med. 2018; 18(3):91-93. PMC: 6107969. DOI: 10.1016/j.tjem.2018.08.001. View

16.

Fu D, Liu A . LncRNA SBF2-AS1 Promotes Diffuse Large B-Cell Lymphoma Growth by Regulating FGFR2 via Sponging miR-494-3p. Cancer Manag Res. 2021; 13:571-578. PMC: 7837595. DOI: 10.2147/CMAR.S284258. View

17.

Gao X, Liu Q, Chen X, Chen S, Yang J, Liu Q . Screening of tumor grade-related mRNAs and lncRNAs for Esophagus Squamous Cell Carcinoma. J Clin Lab Anal. 2021; 35(6):e23797. PMC: 8183932. DOI: 10.1002/jcla.23797. View

18.

Klose R, Kallin E, Zhang Y . JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet. 2006; 7(9):715-27. DOI: 10.1038/nrg1945. View

19.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

20.

Montagut C, Settleman J . Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett. 2009; 283(2):125-34. DOI: 10.1016/j.canlet.2009.01.022. View